Edition:
United States

People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

22.83USD
22 Jul 2019
Change (% chg)

$-0.44 (-1.89%)
Prev Close
$23.27
Open
$23.49
Day's High
$23.62
Day's Low
$22.76
Volume
928,429
Avg. Vol
1,276,886
52-wk High
$46.98
52-wk Low
$21.29

Frates, James 

Mr. James M. Frates is Chief Financial Officer, Senior Vice President and Treasurer of Alkermes Plc. Prior to assuming his current positions, from May 2007 to September 16, 2011, Mr. Frates served as Senior Vice President and Chief Financial Officer of Alkermes, Inc. From June 1998 to May 2007, Mr. Frates served as Vice President, Chief Financial Officer and Treasurer of Alkermes, Inc. From June 1996 to June 1998, he was employed at Robertson, Stephens & Company, most recently as a Vice President in Investment Banking. Prior to that time he was employed at Morgan Stanley & Co. Mr. Frates serves on the board of directors of Sage Therapeutics, a publicly traded biotechnology company. Mr. Frates served on the board of directors of GPC Biotech AG, a biotechnology company, from June 2004 to 2009, and was a national director of the Association of Bioscience Financial Officers from 2004 to 2009. Mr. Frates is also a Trustee of St. Paul’s School and The Roxbury Latin School.

Basic Compensation

Total Annual Compensation, USD 517,232
Restricted Stock Awards, USD 654,840
Long-Term Incentive Plans, USD --
All Other, USD 1,656,470
Fiscal Year Total, USD 2,828,540

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 66,864 2,602,070.00
Name Fiscal Year Total

Richard Pops

9,380,490

James Frates

2,828,540

Elliot Ehrich

3,547,020

Iain Brown

--

David Gaffin

--

Michael Landine

--
As Of  30 Dec 2017